Aug 4 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2017 Jun 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 132 mln 140 mln 773 mln
(-5.7 pct) (+12.7 pct) (+4.2 pct)
Operating loss 59 mln loss 50 mln loss 116 mln
Recurring loss 59 mln loss 60 mln loss 122 mln
Net loss 61 mln loss 62 mln loss 128 mln
EPS loss 8.27 yen loss 8.65 yen loss 17.25 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T
((Tokyo Headline News Desk +813 6441 1812))